Evaluation of carbohydrate and lipid metabolism dynamics in chronic HCV diabetic patients treated with direct antiviral agents
Authors:   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Duport-Dodot Irina ,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Tiliscan Catalin ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Radulescu Mihaela ,   University Hospital Lewisham, London, United Kingdom, Saran Anca ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Stratan Laurentiu ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Negru Anca ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Mihai Nicoleta ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Dodot Mihai ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   Fundeni Clinical Institute, Bucharest, Romania, Croitoru Alexandru ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Arama Victoria ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania, Arama Stefan Sorin ,   “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania,   “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania
Published: July 2023

Although Hepatitis C virus (HCV) infection has become a curable disease, the aftermath of the infection remains an important aspect to be evaluated. HCV infection is well known for its extrahepatic manifestations, mostly the tight relationship between HCV, type 2 diabetes mellitus (T2DM) and dyslipidemia. Not only HCV increases the risk of T2DM, but it also affects its control in diabetic patients, increasing the risk of diabetes related complications. Furthermore, HCV hijacks the lipid metabolism resulting in abnormalities in circulating lipids which can lead to multiple complications, such as increased atherosclerotic risk and hepatic steatosis. Objectives. The aim of this study was to evaluate the dynamics of the parameters of carbohydrate and lipid metabolism in HCV-infected diabetic patients compared to non-diabetic patients after viral eradication. Material and methods. This is a prospective study conducted on 100 patients with chronic HVC infection who obtained viral clearance after interferon-free treatment. 58 patients had type 2 diabetes mellitus and 42 were nondiabetic. We evaluated serum total cholesterol, triglycerides, blood glucose and glycosylated hemoglobin in both groups at treatment initiation and 1 year after. Continuous variables were expressed as mean values ± standard deviation or median, categorical variables were represented as relative or absolute frequencies. Characteristics were compared using the Mann-Whitney method or the two-sample Student's T-test method for continuous variables, Chi-square and Fischer's test for categorical variables. A p value < 0.05 was considered statistically significant. Outcomes. The study analyzed and compared lipid and glycemic profiles of diabetic and non-diabetic HVC patients before and after viral cure. Conclusions. 1 year after treatment initiation the changes in lipid metabolism seem to persist, carbohydrate metabolism seems to remain unchanged, with no differences between diabetic and non-diabetic patients.